{"id":225194,"date":"2024-03-22T13:52:42","date_gmt":"2024-03-22T13:52:42","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=225194"},"modified":"2024-03-22T13:52:42","modified_gmt":"2024-03-22T13:52:42","slug":"oana-mocanu-director-cnas-taxa-clawback-este-diferentiata-si-ofera-o-predictibilitate-detinatorilor-de-autorizatie-de-punere-pe-piata-a-medicamentelor","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=225194","title":{"rendered":"Oana Mocanu, director CNAS: Taxa clawback este diferen\u0163iat\u0103 \u015fi ofer\u0103 o predictibilitate de\u0163in\u0103torilor de autoriza\u0163ie de punere pe pia\u0163\u0103 a medicamentelor"},"content":{"rendered":"<p>\n\u00cen prezent, taxa clawback este diferen\u0163iat\u0103&nbsp;\u015fi ofer\u0103&nbsp;o predictibilitate de\u0163in\u0103torilor de autoriza\u0163ie de punere pe pia\u0163\u0103&nbsp;a medicamentelor, &nbsp;const\u0103&nbsp;\u00een procente fixe, de 15%, respectiv 25%.<\/p>\n<p>\n\u201e25% pl\u0103tesc,&nbsp;\u00een principiu, medicamentele inovative, care nu au niciun generic sau un biosimilar pe pia\u0163a din Rom\u00e2nia iar 15% pl\u0103tesc medicamentele generice, medicamentele biosimilare&nbsp;\u015fi medicamentele genericizate\u201d, a spus Oana Mocanu, director al Casei de S\u0103n\u0103tate (CNAS) \u00een cadrul videoconferin\u0163ei&nbsp;ZF\/GNP: Radiografia reglement\u0103rilor sistemului sanitar din Rom\u00e2nia.<\/p>\n<p>\nTaxa clawback a fost introdus\u0103&nbsp;ca un mecanism de sus\u0163inere a cheltuielilor bugetului Fondului de Asigur\u0103ri Sociale de S\u0103n\u0103tate cu medicamente,&nbsp;\u00een condi\u0163iile&nbsp;\u00een care resursele alocate sunt limitate, potrivit ei.<\/p>\n<p>\n\u201eContractele cost-volum-rezultat sunt mecanisme de acces care urm\u0103resc at\u00e2t managementul impactului bugetar c\u00e2t&nbsp;\u015fi managementul eficacit\u0103\u0163ii&nbsp;\u015fi utiliz\u0103rii medicamentului &nbsp;prin urm\u0103rirea unui rezultat clinic predefinit. Dac\u0103&nbsp;\u00een anul 2015&nbsp;au intrat&nbsp;\u00een vigoare primele contracte cost-volum&nbsp;\u015fi cost-volum-rezultat,&nbsp;\u00een num\u0103r de cinci&nbsp;pe aria terapeutic\u0103&nbsp;hepatic\u0103&nbsp;viral\u0103&nbsp;cronic\u0103,&nbsp;am ajuns ca \u00een prezent, la sf\u00e2r\u015fitul anului 2023, s\u0103&nbsp;avem&nbsp;\u00een derulare 81 de contracte cost-volum&nbsp;\u015fi cost-volum rezultat, adic\u0103&nbsp;medicamente efectiv incluse&nbsp;\u00een list\u0103\u201d<\/p>\n<p>\nCreditele de angajament alocate pentru medicamentele cost-volum&nbsp;\u015fi cost-volum rezultat au fost&nbsp;\u00een cre\u015ftere&nbsp;\u00een 2022 fa\u0163\u0103&nbsp;de 2021 cu 62%,&nbsp;\u00een 2023 au crescut cu 86% fa\u0163\u0103&nbsp;de 2021&nbsp;\u015fi cu 15% fa\u0163\u0103&nbsp;de 2022,&nbsp; a mai precizat ea.<\/p>\n<p>\n\u00cen ultimii 25 de ani, suma care a intrat la bugetul Casei Na\u0163ionale de Asigur\u0103ri de S\u0103n\u0103tate (CNAS) din contribu\u0163iile sociale de s\u0103n\u0103tate ale asigura\u0163ilor a crescut de 30 de ori, de la 1,8 miliarde de lei la 54 miliarde de lei anul trecut, arat\u0103 datele publice.&nbsp;Fondul Na\u0163ional Unic de Asigur\u0103ri Sociale de S\u0103n\u0103tate &nbsp;(FNUASS) este gestionat de Casa Na\u0163ional\u0103 de Asigur\u0103ri \u015fi este alimentat practic \u00een fiecare an de contribu\u0163iile la s\u0103n\u0103tate din banii asigura\u0163ilor.<\/p>\n<p>\n<br \/>\n&nbsp;<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00cen prezent, taxa clawback este diferen\u0163iat\u0103&nbsp;\u015fi ofer\u0103&nbsp;o predictibilitate de\u0163in\u0103torilor de autoriza\u0163ie de punere pe pia\u0163\u0103&nbsp;a medicamentelor, &nbsp;const\u0103&nbsp;\u00een procente fixe, de 15%, respectiv 25%. \u201e25% pl\u0103tesc,&nbsp;\u00een principiu, medicamentele inovative, care nu au niciun generic sau un biosimilar pe pia\u0163a din Rom\u00e2nia iar 15% pl\u0103tesc medicamentele generice, medicamentele biosimilare&nbsp;\u015fi medicamentele genericizate\u201d, a spus Oana Mocanu, director al [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[13522,10157,452,57230,34613],"class_list":["post-225194","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-autorizatie","tag-cost","tag-director","tag-oana-mocanu","tag-taxa-clawback"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/225194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=225194"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/225194\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=225194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=225194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=225194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}